Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, Xu Q (2023) Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
The test examines variants in other key genes across 14 peptide pathways, helping PlexusDx providers identify whether you're genetically predisposed to slower metabolic adjustment or energy fluctuations
Improve treatment adherence Sticking with a GLP-1 regimen is key to seeing real results
doi:10.15605/jafes.037.02.14 50
Marketing teams must align with this broader clinical picture by emphasizing: Long-term metabolic and cardiovascular outcomes Improved patient adherence through oral administration Holistic care models integrating lifestyle, pharmacology, and education Positioning oral GLP1s in this expanded therapeutic context creates differentiation and deeper provider trust